New injection aims to shrink skin tumors before surgery
Disease control
Ongoing
This early-stage trial tests a drug called PH-762, injected directly into skin tumors, for people with squamous cell carcinoma, melanoma, or Merkel cell carcinoma. Participants receive four weekly injections into one tumor, then have it surgically removed about two weeks later. T…
Phase: PHASE1 • Sponsor: Phio Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC